微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.08% | 0.48% | 118.95% | 63/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.95% | 5.56% | -77.54% | 70/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 4.23% | -26.43% | 18.49% | 60/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 3.57% | -36.48% | 72.46% | 66/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 2.07% | -30.3% | 130% | 68/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.9% | -33.82% | -84.35% | 73/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 5.75% | 67.15% | 2.31% | 56/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 5.62% | 5.24% | 89.23% | 49/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.97% | -24.43% | 118.38% | 63/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.36% | -47.89% | -60.47% | 64/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 3.44% | -77.5% | -35.58% | 81/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 5.34% | -50.42% | 35.88% | 61/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 3.93% | -42.21% | 50.57% | 60/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.61% | -3.69% | -82.93% | 49/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 15.29% | 27.63% | 41.97% | 40/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 10.77% | -6.35% | 58.38% | 53/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.8% | -14.03% | 150.92% | 55/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.71% | -54.53% | -77.38% | 60/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 11.98% | -87.22% | 4.17% | 71/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 11.5% | -86.62% | 45.39% | 51/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 7.91% | -85.11% | 32.72% | 52/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 5.96% | -2.77% | -93.64% | 30/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 93.71% | 944.7% | 9.05% | 10/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 85.93% | 944.11% | 61.8% | 3/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 53.11% | 1881.72% | 766.39% | 9/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 6.13% | 127.88% | -31.66% | 13/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 8.97% | -14.81% | 8.99% | 83/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 8.23% | -18.6% | 207.09% | 39/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 2.68% | -31.63% | -0.37% | 56/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.69% | -22.25% | -74.45% | 24/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 10.53% | -39.13% | 4.15% | 67/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 10.11% | 2% | 157.91% | 22/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.92% | -52.43% | 13.29% | 38/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 3.46% | 2% | -80% | 21/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 17.3% | 5.88% | 109.95% | 39/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-06-30 | 8.24% | 2% | -49.57% | 17/141 | 6.11% | 大博医疗 | 30.55% | 行业排名> |
| 2016-12-31 | 16.34% | 2% | 2% | 31/141 | 16.44% | 基蛋生物 | 23.11% | 行业排名> |